Health Care: Drugs

GlaxoSmithKline PLC (GSK: NYSE)

$52.65 0.44 | 0.84%
05/21/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 42.71B 42.52B 43.82B 45.87B
Cost of Sales 10.42B 9.17B 9.13B 9.41B
Gross Operating Profit 32.29B 33.35B 34.69B 36.46B
Selling, General, and Administrative Expenses 14.12B 13.70B 20.15B 15.51B
Research & Development 6.41B 6.22B 6.88B 6.64B
Operating Income before D & A (EBITDA) 11.76B 13.42B 7.67B 14.31B
Depreciation & Amortization 2.34B 2.21B 2.59B 2.53B
Interest Income 127.66M 139.73M 179.03M 113.19M
Other Income - Net 2.57B 1.84B 898.26M 2.12B
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 12.12B 13.19B 6.16B 14.03B
Interest Expense 1.31B 1.24B 1.28B 1.27B
Pre-Tax Income 10.81B 11.95B 4.87B 12.76B
Income Taxes 3.15B 3.48B 2.01B 3.59B
Minority Interest 289.26M 305.86M 338.00M 223.15M
Net Income From Continuing Operations 7.67B 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 7.67B 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 7.38B 8.17B 2.52B 8.94B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 7.67B 0.00 0.00 0.00
Preferred Dividends
Net Income Available To Common 7.67B 0.00 0.00 0.00
Basic EPS from Continuing Ops. 3.00 3.25 0.99 3.53
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.00 3.25 0.99 3.53
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.00 3.25 0.99 3.53
Basic Normalized Net Income/Share 3.00 n.a. n.a. n.a.
EPS fr Continuing Ops. 2.96 3.20 0.98 3.50
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.96 3.20 0.98 3.50
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.96 3.20 0.98 3.50
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 2.96 n.a. n.a. n.a.
Dividends Paid per Share 2.48 2.21 2.00 1.85

Portfolios with GSK

View All

Latest GSK Headlines from TheStreet

More Financial News for GSK

Press Releases for GSK

See All Press Releases

Partner Headlines for GSK

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter